Position in INCY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$562,378
+$99,402 QoQ
Shares Held
4,961
+0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#504
of 854 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names. INCY ranks #7 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
3,962,177 | $344,511,290 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,389 | $2,676,877 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
86,557 | $2,668,552 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,063 | $662,823 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
1,699 | $631,467 | |
| 6 | ARGX |
Argenx SE
|
640 | $593,772 | |
| 7 | INCY |
Incyte Corp
This page
|
4,961 | $562,378 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
13,833 | $539,625 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $562,378 | 4,961 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $462,976 | 4,919 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $495,825 | 5,020 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $403,441 | 4,757 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $329,059 | 4,832 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $268,781 | 4,439 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $354,260 | 5,129 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $356,345 | 5,391 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $256,665 | 4,234 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $113,541 | 1,993 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $108,815 | 1,733 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $214,095 | 3,706 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $55,402 | 890 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $216,520 | 2,996 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $179,193 | 2,231 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $109,089 | 1,637 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $61,307 | 807 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $77,513 | 976 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $58,499 | 797 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $55,024 | 800 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $30,791 | 366 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $16,416 | 202 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $28,616 | 329 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $105,175 | 1,172 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $137,656 | 1,324 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $49,942 | 682 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||